Sumatriptan relaxes isolated porcine ophthalmic artery, but inhibits VIP-induced relaxation.
Sumatriptan, a 5-hydroxytryptamine (5HT)1-like receptor agonist, is a new antimigraine drug which is also effective in cluster headache (CH), a disorder with marked ocular circulatory abnormalities. Sumatriptan could putatively exert a therapeutic effect in this vascular bed. The present study is an attempt to assess sumatriptan's vasoactivity in isolated porcine ophthalmic artery (POA) and to verify whether it has similar activity to 5HT, and whether it interferes with the vasodilation induced by calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP). In contrast to 5HT, sumatriptan induced only slight contraction in POA at high concentrations. However, in some artery segments pre-contracted with PGF2 alpha, sumatriptan induced a slight and short-lasting but marked relaxation. In addition, relaxations induced by VIP were inhibited significantly by sumatriptan, whereas CGRP effects were not influenced by the drug. Such reactions suggest that sumatriptan's effect in CH is probably unrelated to direct ocular arterial vasoconstriction.
Vincent
M B
MB
Department of Neurology, University of Trondheim-NTH, Norway.
White
L R
LR
Bakken
I J
IJ
Sjaastad
O
O
D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology; D066298:In Vitro Techniques; D009880:Ophthalmic Artery / Q000187:drug effects*; D018170:Sumatriptan / Q000494:pharmacology*; D013552:Swine; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*; D014661:Vasoconstriction; D014664:Vasodilation / Q000187:drug effects*
D014660:Vasoactive Intestinal Peptide; D018170:Sumatriptan; D015740:Calcitonin Gene-Related Peptide